openPR Logo
Press release

Multiplex Assays Market 2024-2033: Growth Trends, Forecast & Competitive Landscape

Multiplex Assays Market 2024-2033: Growth Trends, Forecast &

The multiplex assays market size has grown strongly in recent years. It will grow from $3.61 billion in 2023 to $3.96 billion in 2024 at a compound annual growth rate (CAGR) of 9.7%. The growth in the historic period can be attributed to increased healthcare expenditure, emerging markets growth, rapid technological advances and a rapid growth in aging population.

The multiplex assays market size is expected to see strong growth in the next few years. It will grow to $5.7 billion in 2028 at a compound annual growth rate (CAGR) of 9.5%. The growth in the forecast period can be attributed to the rise in funding, government initiatives for genetic and microbiological research, aging population, increasing prevalence of chronic diseases and a rapid rise in various bacterial and viral epidemics. Major trends in the forecast period include the rise in funding, government initiatives for genetic and microbiological research, aging population, increasing prevalence of chronic diseases and a rapid rise in various bacterial and viral epidemics.

Market Overview -
Multiplex assays are used to amplify multiple targets in a polymerase chain response (PCR) trial and collect further information from nanosecond amounts of proteins or other analyses in lower time as compared to the conventional system, similar to ELISA. Multiplex assays are used for pathogen identification, mutation analysis, RNA discovery, gene discovery analysis, relation analysis, forensic studies, and others.

Download Free Sample of Report -
https://www.thebusinessresearchcompany.com/sample.aspx?id=5775&type=smp

Rising Incidence Of Chronic Diseases Propels Growth In The Global Multiplex Assay Market
An increased incidence of chronic diseases is driving the growth of the global multiplex assay market. Multiplex assay is extensively used in clinical trials to analyze and study the efficacy of a disease and for the detection of antibodies against those diseases. According to the World Health Organization (WHO) report published in April 2021, chronic diseases, also known as non-communicable diseases (NCDs), kill 41 million people each year, equivalent to 71% of all deaths globally. Every year, between the ages of 30 and 69 years, more than 15 million people die from an NCD. Due to the growing acceptance and the advantages of multiplex assays over traditional assays, such as quicker analysis, the market for multiplex assays is expected to develop rapidly, driving growth in the forecast period.

Competitive Landscape -
Major companies operating in the multiplex assays market report are Seegene Inc, DiaSorin SpA, Thermo Fisher Scientific Inc, Bio-Rad Laboratories Inc, Qiagen NV, Abcam Plc, PerkinElmer Inc, Hologic Corporation, Meso Scale Diagnostics, Merck KGaA, Roche Diagnostics India Pvt Ltd, bioMérieux India, Becton Dickinson Private Limited, Danaher Corporation, Johnson & Johnson, Simens Healthcare, Beckman Coulter Inc. India, Ortho Clinical Diagnostics, Sysmex Corporation, Siemens Healthineers Ukraine, TestLine Clinical Diagnostics s.r.o., Cepheid, F. Hoffmann-La Roche Ltd., Hologic, Bayer AG, Cantel Medical Corporation, Meridian Bioscience, Dexcom Inc., Medtronic Inc., Senseonics Holdings Inc., Adavium Medical, DK Diagnostics, Crosmed, Ortopedia Alemana, Simed, Ab Enzymes Gmbh, Bluestar Adisseo Co., BASF SE, Chr. Hansen Holding, Novozymes, BiotechAfrica, Faizyme Laboratories, Alere Inc., Bangs Laboratories Inc, The Merck Group, Takara Bio Inc, Qiagen, Spherotech Inc, Geneaid Biotech Ltd, Rockland Immunochemicals Inc, GenScript Biotech Corporation

Quantumdx Group Introduces Cutting-Edge Multiplex Respiratory Panel Test To Reinforce Market Presence
Companies in the market are launching innovative tests based on multiplex assays to strengthen their position in the market. For instance, in May 2022, QuantuMDx Group Limited, a UK-based developer of transformational point-of-care diagnostics, launched its new respiratory panel test, the Q-POC SARS-CoV-2, Flu A/B, and RSV (respiratory syncytial virus) Assay. The Q-POCTM SARS (severe acute respiratory syndrome)-CoV-2, Flu A/B, and RSV Assay is a multiplex panel that can detect SARS-CoV-2, Flu A, Flu B, and RSV (respiratory syncytial virus) at the point of need.

Browse Full Report @
https://www.thebusinessresearchcompany.com/report/multiplex-assays-global-market-report

Key Segments -
The multiplex assays market covered in this report is segmented -
1) By Type: Protein-Based Multiplex Assays, Nucleic Acid-Based Multiplex Assays, Other Types
2) By Identification Technology: Flow Cytometry, Multiplex Real-Time PCR, Other Identification Technologies
3) By Detection Technology: Enzyme-Linked Immunosorbent Assay (ELISA), Luminescence, Fluorescence, Other Detection Technologies
4) By Application: Research And Development, Clinical Diagnostics
5) By End User: Pharmaceutical And Biotechnology Companies, Hospitals And Research Institutes, Reference Laboratories, Other End-Users

Key highlights covered in the report -
1. Detailed market size forecast and historical data analysis
2. Key drivers influencing market growth
3. Identification of upcoming trends and potential opportunities in the market
4. Analysis of major players strategies, to understand competitive dynamics and market positioning
5. Evaluation of regional dynamics

Contact Us:
The Business Research Company
Europe: +44 207 1930 708
Asia: +91 88972 63534
Americas: +1 315 623 0293
Email: info@tbrc.info

Follow Us On:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
Twitter: https://twitter.com/tbrc_info
Facebook: https://www.facebook.com/TheBusinessResearchCompany
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Blog: https://blog.tbrc.info/
Healthcare Blog: https://healthcareresearchreports.com/
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model

Want To Know More About The Business Research Company?
The Business Research Company (www.thebusinessresearchcompany.com) is a market intelligence firm that pioneers in company, market, and consumer research. Located globally, TBRC's consultants specialise in various industries including manufacturing, healthcare, financial services, chemicals, and technology.

Global Market Model - World's Most Comprehensive Database
The Business Research Company's flagship product, Global Market Model (www.thebusinessresearchcompany.com/global-market-model) is a market intelligence platform covering various macroeconomic indicators and metrics across 60 geographies and 27 industries. The Global Market Model covers multi-layered datasets which help its users assess supply-demand gaps

This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release Multiplex Assays Market 2024-2033: Growth Trends, Forecast & Competitive Landscape here

News-ID: 3468202 • Views:

More Releases from The Business research company

Biotech Ingredient Market Size, New Opportunities, Share, Growth, Key Segments And Forecast 2033
Biotech Ingredient Market Size, New Opportunities, Share, Growth, Key Segments A …
The biotech ingredient market size has grown strongly in recent years. It will grow from $56.76 billion in 2023 to $60.6 billion in 2024 at a compound annual growth rate (CAGR) of 6.8%. The growth in the historic period can be attributed to innovations in food and beverage industry, increasing adoption of biofuel, consumer demand for functional foods, advances in genetic engineering. The biotech ingredient market size is expected to
Autonomous Boats Market Size, Share, Trends, Growth And Forecast To 2033
Autonomous Boats Market Size, Share, Trends, Growth And Forecast To 2033
The autonomous boats market size has grown strongly in recent years. It will grow from $1.17 billion in 2023 to $1.26 billion in 2024 at a compound annual growth rate (CAGR) of 7.8%. The growth in the historic period can be attributed to market acceptance, cost reduction, investment trends, regulatory frameworks, historical use cases. The autonomous boats market size is expected to see strong growth in the next few years.
Automotive LED Lighting Market Analysis, Size, Share, Trends, Growth And Forecast To 2033
Automotive LED Lighting Market Analysis, Size, Share, Trends, Growth And Forecas …
The automotive led lighting market size has grown strongly in recent years. It will grow from $18.84 billion in 2023 to $20.24 billion in 2024 at a compound annual growth rate (CAGR) of 7.4%. The growth in the historic period can be attributed to consumer demand, environmental concerns, improved performance, cost reduction, safety and visibility. The automotive led lighting market size is expected to see strong growth in the next
Automated Nucleic Acid Extraction Devices Market In-depth Analysis, New Opportunities And Forecast Till 2033
Automated Nucleic Acid Extraction Devices Market In-depth Analysis, New Opportun …
The automated nucleic acid extraction devices market size has grown rapidly in recent years. It will grow from $5.41 billion in 2023 to $6.09 billion in 2024 at a compound annual growth rate (CAGR) of 12.5%. The growth in the historic period can be attributed to increasing demand for molecular diagnostics, growing awareness of the benefits of automation, expansion of the pharmaceutical and biotechnology industries, government initiatives to promote

All 5 Releases


More Releases for Multiplex

Preference of Multiplex Assays over Conventional Assays Boosts Global Multiplex …
According to a new market research report launched by Inkwood Research, the Global Multiplex Assay Market is estimated to reach around $7922.13 million by 2028, progressing with a CAGR of 8.74% over the forecasting years. Browse 61 market data Tables and 51 Figures spread over 230 Pages, along with in-depth analysis on Global Multiplex Assay Market by Type, End-User, Product, Technology, Application & by Geography. This insightful market research report by Inkwood
Multiplex Assays Market Future Adoption Overview 2028
Multiplex Assays Market: Snapshot The global multiplex assays market has been displaying an upward movement in its valuation over the last few years. The significant surge in the need for efficient analytical platforms in R&D to reduce the operational cost is boosting the demand for multiple assays across the world. Apart from this, the rising uptake of companion diagnostics to increase the efficacy of therapies and the growing awareness about the
Multiplex Assays Market Segmented into types, Applications 2025
Multiplex Assays Market: Snapshot The global market for multiplex assays has been displaying an upward movement in its valuation over the last few years. The significant surge in the need for efficient analytical platforms in R&D to reduce the operational cost is boosting the demand for multiple assays across the world. Apart from this, the rising uptake of companion diagnostics to increase the efficacy of therapies and the growing awareness about
Multiplex Assays Market Malleable Strategies in 2025
Multiplex Assays Market: Snapshot The global market for multiplex assays has been displaying an upward movement in its valuation over the last few years. The significant surge in the need for efficient analytical platforms in R&D to reduce the operational cost is boosting the demand for multiple assays across the world. Apart from this, the rising uptake of companion diagnostics to increase the efficacy of therapies and the growing awareness about
Multiplex Assays Market Prominent Growth Rate by 2025
Multiplex Assays Market: Snapshot The global market for multiplex assays has been displaying an upward movement in its valuation over the last few years. The significant surge in the need for efficient analytical platforms in R&D to reduce the operational cost is boosting the demand for multiple assays across the world. Apart from this, the rising uptake of companion diagnostics to increase the efficacy of therapies and the growing awareness about
Multiplex Biomarker Imaging Market Outlook Report 2027
The global multiplex biomarker imaging market is estimated to be valued at US$ 270 Mn in the year 2017 and is estimated to touch a value of US$ 843 Mn in the year 2027, exhibiting a CAGR of 12% during the period of assessment (2017-2027). Request for TOC @ https://www.futuremarketinsights.com/reports/multiplex-biomarker-imaging-market/toc Increased spending on cancer diagnostic and monitoring Growing incidence of cancer is resulting in increased spending by governments in various countries globally. Complications arising